Xilio Therapeutics, Inc. (XLO)
9.00
+0.09
(+1.01%)
USD |
NASDAQ |
Sep 09, 14:00
Xilio Therapeutics Price to Book Value : 0.8195 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.8113 |
| September 04, 2026 | 0.8195 |
| September 03, 2026 | 0.8213 |
| September 02, 2026 | 0.8049 |
| September 01, 2026 | 0.8086 |
| August 31, 2026 | 0.815 |
| August 28, 2026 | 0.8195 |
| August 27, 2026 | 0.8204 |
| August 26, 2026 | 0.8241 |
| August 25, 2026 | 0.8268 |
| August 24, 2026 | 0.8368 |
| August 21, 2026 | 0.8405 |
| August 20, 2026 | 0.8405 |
| August 19, 2026 | 0.8568 |
| August 18, 2026 | 0.865 |
| August 17, 2026 | 0.8641 |
| August 14, 2026 | 0.835 |
| August 13, 2026 | 0.8204 |
| August 12, 2026 | 0.8241 |
| August 11, 2026 | 0.8359 |
| August 10, 2026 | 0.8377 |
| August 07, 2026 | 0.835 |
| August 06, 2026 | 0.8441 |
| August 05, 2026 | 0.8295 |
| August 04, 2026 | 0.8277 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.8241 |
| July 31, 2026 | 0.8295 |
| July 30, 2026 | 0.8268 |
| July 29, 2026 | 0.8286 |
| July 28, 2026 | 0.8332 |
| July 27, 2026 | 0.8277 |
| July 24, 2026 | 0.7876 |
| July 23, 2026 | 0.7567 |
| July 22, 2026 | 0.7722 |
| July 21, 2026 | 0.7922 |
| July 20, 2026 | 0.7804 |
| July 17, 2026 | 0.8086 |
| July 16, 2026 | 0.8222 |
| July 15, 2026 | 0.8304 |
| July 14, 2026 | 0.8222 |
| July 13, 2026 | 0.8414 |
| July 10, 2026 | 0.8286 |
| July 09, 2026 | 0.8377 |
| July 08, 2026 | 0.845 |
| July 07, 2026 | 0.8477 |
| July 06, 2026 | 0.8596 |
| July 02, 2026 | 0.8332 |
| July 01, 2026 | 0.8395 |
| June 30, 2026 | 0.8723 |
| June 29, 2026 | 0.7389 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cue Biopharma, Inc. | 69.95 |
| ACADIA Pharmaceuticals, Inc. | 3.669 |
| Alnylam Pharmaceuticals, Inc. | 25.18 |
| Anika Therapeutics, Inc. | 2.037 |
| Savara, Inc. | 7.714 |
Price to Book Value Related Metrics
| PS Ratio | 2.067 |
| Price | 9.00 |
| Earnings Yield | -18.73% |
| Market Cap | 59.22M |